» Articles » PMID: 31320877

Functionality and Quality of Life of Patients with Unilateral Lymphedema of a Lower Limb: a Cross-sectional Study

Abstract

Background: Lymphedema of the lower limbs is a chronic disease caused by damage to the lymphatic system that influences people's mobility, functionality, and quality of life. Questionnaires and physical test are very practical, easy to apply, and low cost methods that provide important data for evaluation of these patients.

Objectives: To evaluate the influence of unilateral lower limb lymphedema on functionality and quality of life, correlating 3 assessment tools.

Methods: This was a descriptive study investigating 25 patients of both sexes with unilateral lymphedema in a lower limb. Limb volume was assessed using circumferential tape measurements, the Medical Outcomes Study Short Form-36 Health Survey (SF-36) was used to assess quality of life, the Lymphoedema Functioning, Disability and Health Questionnaire for Lower Limb Lymphoedema (Lymph-ICF-LL) was used to assess physical, mental, and social skills related to lymphedema, and the Timed Up and Go (TUG) test was used for functional assessment.

Results: Lymphedema was present throughout the affected lower limb of participants. The domains most affected by lymphedema were physical aspects (25.0 ± 31.4) and emotional aspects (36.0 ± 42.9) from the SF-36 and the mobility domain (6.0 ± 2.6) from the Lymph -ICF-LL. Patients performed the TUG in 9.88 ± 1.98 seconds. The TUG was correlated with the questionnaires and the questionnaires were correlated with each other.

Conclusions: People with unilateral lower limb lymphedema exhibited negative impacts on quality of life and functionality, as evaluated by questionnaires, which were correlated with each other. TUG performance was within normal limits, but results correlated with the questionnaires used.

Citing Articles

Coping Mechanisms for Lymphedema: An Analysis of Patient Experiences.

Admoun C, Mayrovitz H Cureus. 2023; 15(7):e41573.

PMID: 37554614 PMC: 10406395. DOI: 10.7759/cureus.41573.


Depressive symptoms and their severity in a sample with lymphedema: a case-control investigation.

Monteiro A, de Labra C, Losa-Iglesias M, Dias A, Becerro-de-Bengoa-Vallejo R, Silva-Migueis H Front Psychiatry. 2023; 14:1202940.

PMID: 37476539 PMC: 10354281. DOI: 10.3389/fpsyt.2023.1202940.


Home-Based Intermittent Pneumatic Compression Therapy: The Impact in Chronic Leg Lymphedema in Patients Treated for Gynecologic Cancer.

Kim Y, Kim S, Lim J, Hwang C, Ko M, Hwang J Healthcare (Basel). 2022; 10(4).

PMID: 35455817 PMC: 9032801. DOI: 10.3390/healthcare10040638.


Lymphatic Filariasis: A Systematic Review on Morbidity and Its Repercussions in Countries in the Americas.

Medeiros Z, Vieira A, Xavier A, Bezerra G, Lopes M, Bonfim C Int J Environ Res Public Health. 2022; 19(1).

PMID: 35010576 PMC: 8751179. DOI: 10.3390/ijerph19010316.


The Lymph-Sparing Quotient: A Retrospective Risk Analysis on Extremity Radiation for Soft Tissue Sarcoma Treatment.

Sarif I, Elsayad K, Rolf D, Kittel C, Gosheger G, Wardelmann E Cancers (Basel). 2021; 13(9).

PMID: 33925683 PMC: 8125651. DOI: 10.3390/cancers13092113.


References
1.
Miller A, Bruna J, BENINSON J . A universally applicable clinical classification of lymphedema. Angiology. 1999; 50(3):189-92. DOI: 10.1177/000331979905000302. View

2.
Franks P, Moffatt C, Doherty D, Williams A, Jeffs E, Mortimer P . Assessment of health-related quality of life in patients with lymphedema of the lower limb. Wound Repair Regen. 2006; 14(2):110-8. DOI: 10.1111/j.1743-6109.2006.00099.x. View

3.
Thomas-Maclean R, Miedema B, Tatemichi S . Breast cancer-related lymphedema: women's experiences with an underestimated condition. Can Fam Physician. 2006; 51:246-7. PMC: 1472970. View

4.
Farrelly I . The importance and function of footwear in managing lymphoedema. Br J Community Nurs. 2008; 13(10):S10-4. DOI: 10.12968/bjcn.2008.13.Sup5.31190. View

5.
Lawenda B, Mondry T, Johnstone P . Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. CA Cancer J Clin. 2009; 59(1):8-24. DOI: 10.3322/caac.20001. View